Risk of Thrombosis during and after COVID Infection

The novel coronavirus known as SARS-CoV-2 is a respiratory virus that presents with symptoms such as a non-productive cough (60-80%), fever (90%) and shortness of breath (19-40%) and is responsible for the 2019-2020 global coronavirus disease (COVID-19) pandemic. Although most patients experience mild or no symptoms, severe disease is associated with thromboembolic complications and respiratory failure. There is an observed rise in the clinical manifestations of the disease 7 to 14 days after initial symptom onset and also associated with thrombotic complications. Understanding the thrombotic manifestations of the virus is important for patient management.

Autorentext

Asst. Prof. Noha El-Sayed Ibrahim, Department of Microbial Biotechnology, Biotechnology Research Institute, National Research Centre.Asst. Prof. Wael Mahmoud Aboulthana, Biochemistry Department, Biotechnology Research Institute, National Research Centre.